| # | Drug | Count |
|---|---|---|
| 0 | AMOXICILLIN | 82 |
| 1 | RITUXIMAB | 56 |
| 2 | INFLIXIMAB | 48 |
| 3 | DUPILUMAB | 43 |
| 4 | IBUPROFEN | 38 |
| 5 | ACETAMINOPHEN | 32 |
| 6 | PREDNISONE | 28 |
| 7 | FLUOXETINE | 26 |
| 8 | FLUOXETINE HYDROCHLORIDE | 26 |
| 9 | ACETAMINOPHEN 500MG | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN RABIES VIRUS IMMUNE GLOBULIN | 1 | 0.0156 |
| 1 | BOTULISM ANTITOXIN HEPTAVALENT | 2 | 0.0155 |
| 2 | NAXITAMAB | 3 | 0.0120 |
| 3 | CROVALIMAB | 1 | 0.0083 |
| 4 | ALUMINUM HYDROXIDE GEL | 1 | 0.0068 |
| 5 | SECNIDAZOLE | 1 | 0.0035 |
| 6 | NITAZOXANIDE | 1 | 0.0029 |
| 7 | BUPROPION HCL ER | 1 | 0.0021 |
| 8 | LENACAPAVIR SODIUM | 1 | 0.0020 |
| 9 | SODIUM THIOSULFATE | 1 | 0.0018 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Interleukin-5 Antagonist [EPC] | 4 | 0.0058 |
| 2 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 3 | Cephalosporin Antibacterial [EPC] | 6 | 0.0007 |
| 4 | Macrolide Antimicrobial [EPC] | 28 | 0.0005 |
| 5 | Antiseptic [EPC] | 2 | 0.0005 |
| 6 | beta Lactamase Inhibitor [EPC] | 2 | 0.0004 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 3 | 0.0004 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 23 | 0.0003 |